Literature DB >> 29172646

3,7-Dideazaneplanocin: Synthesis and antiviral analysis.

Xue-Qiang Yin1, Stewart W Schneller1.   

Abstract

Objective To synthesize 3,7-dideazaneplanocin and evaluate its antiviral potential. Methods The target n class="Chemical">3,7-dideazaneplanocin has been prepared in five steps from a readily available cyclopentenol. A thorough in vitro antiviral analysis was conducted versus both DNA and RNA viruses. Results A rational synthesis of 3,7-dideazaneplanocin was conceived and successfully pursued in such a way that it can be adapted to various analogs of 3,7-dideazaneplanocin. Using standard antiviral assays, no activity for 3,7-dideazaneplanocn was found. Conclusion Two structural features are necessary for adenine-based carbocyclic nucleosides (like neplanocin) for potential antiviral properties: (i) inhibition of S-adenosylhomocysteine hydrolase and/or (ii) C-5' activation via the mono-nucleotide. These two requisite adenine structural features to fit these criteria are not present in in the target 3,7-dideazaneplanocin: (i) an N-7 is necessary for inhibition of the hydrolase and the N-3 is claimed to be essential for phosphorylation at C-5'. Thus, it is not surprising that 3,7-dideazaneplaoncin lacked antiviral properties.

Entities:  

Keywords:  3,7-dideazaadenine nucleosides; Carbocyclic nucleosides; antiviral activity; neplanocin

Mesh:

Substances:

Year:  2017        PMID: 29172646      PMCID: PMC5890514          DOI: 10.1177/2040206617742561

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  11 in total

Review 1.  S-adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy.

Authors:  M S Wolfe; R T Borchardt
Journal:  J Med Chem       Date:  1991-05       Impact factor: 7.446

2.  The history of antiretrovirals: key discoveries over the past 25 years.

Authors:  Erik De Clercq
Journal:  Rev Med Virol       Date:  2009-09       Impact factor: 6.989

3.  Streptomyces citricolor nov. sp. and a new antibiotic, aristeromycin.

Authors:  T Kusaka; H Yamamoto; M Shibata; M Muroi; T Kishi
Journal:  J Antibiot (Tokyo)       Date:  1968-04       Impact factor: 2.649

4.  Synthesis and antiviral activities of 3-deaza-3-fluoroaristeromycin and its 5' analogues.

Authors:  Qi Chen; Chong Liu; Gloria Komazin; Terry L Bowlin; Stewart W Schneller
Journal:  Bioorg Med Chem       Date:  2014-11-06       Impact factor: 3.641

Review 5.  Entecavir: a potent new antiviral drug for hepatitis B.

Authors:  P Honkoop; R A De Man
Journal:  Expert Opin Investig Drugs       Date:  2003-04       Impact factor: 6.206

6.  Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities.

Authors:  C K Tseng; V E Marquez; R W Fuller; B M Goldstein; D R Haines; H McPherson; J L Parsons; W M Shannon; G Arnett; M Hollingshead
Journal:  J Med Chem       Date:  1989-07       Impact factor: 7.446

7.  Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities.

Authors:  Girish Chandra; Yang Won Moon; Yoonji Lee; Ji Yong Jang; Jayoung Song; Akshata Nayak; Kawon Oh; Varughese A Mulamoottil; Pramod K Sahu; Gyudong Kim; Tong-Shin Chang; Minsoo Noh; Sang Kook Lee; Sun Choi; Lak Shin Jeong
Journal:  J Med Chem       Date:  2015-06-05       Impact factor: 7.446

8.  Synthesis and anti-hepatitis B virus and anti-hepatitis C virus activities of 7-deazaneplanocin A analogues in vitro.

Authors:  Hyo-Joong Kim; Ashoke Sharon; Chandralata Bal; Jianing Wang; Madhan Allu; Zhuhui Huang; Michael G Murray; Leda Bassit; Raymond F Schinazi; Brent Korba; Chung K Chu
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

9.  Studies on neplanocin A, new antitumor antibiotic. I. Producing organism, isolation and characterization.

Authors:  S Yaginuma; N Muto; M Tsujino; Y Sudate; M Hayashi; M Otani
Journal:  J Antibiot (Tokyo)       Date:  1981-04       Impact factor: 2.649

10.  Synthesis and antiviral activity of 7-deazaneplanocin A against orthopoxviruses (vaccinia and cowpox virus).

Authors:  Balakumar Arumugham; Hyo-Joong Kim; Mark N Prichard; Earl R Kern; Chung K Chu
Journal:  Bioorg Med Chem Lett       Date:  2005-11-03       Impact factor: 2.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.